MBF Therapeutics is an immunotherapeutic animal health company based in Ambler, PA, specializing in the development of disruptive products for infectious diseases and cancer using its innovative T-Max DNA vaccine platform.
The company focuses on creating highly efficacious, universal vaccines for animals, with potential applications in humans, to prevent current and emerging infectious diseases. MBF Therapeutics aims to address serious health problems in animal health while establishing proof of concept clinical data for human health opportunities through partnerships with major vaccine companies.
Generated from the website